SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-025698
Filing Date
2023-09-12
Accepted
2023-09-12 16:15:18
Documents
13
Period of Report
2023-09-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20230908_8k.htm   iXBRL 8-K 27326
  Complete submission text file 0001437749-23-025698.txt   175061

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcda-20230906.xsd EX-101.SCH 3850
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20230906_def.xml EX-101.DEF 13381
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20230906_lab.xml EX-101.LAB 17545
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20230906_pre.xml EX-101.PRE 13358
7 EXTRACTED XBRL INSTANCE DOCUMENT bcda20230908_8k_htm.xml XML 4247
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 231250245
SIC: 2836 Biological Products, (No Diagnostic Substances)